SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,028.02 1,718.01
( 2.17%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

629.4942217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

91.32

273565.37

EPS(TTM)

Face Value()

Div & Yield %

112.85

0.29

Back

Geojit Financial Services consolidated net profit declines 26.06% in the September 2026 quarter

Oct 24,2026

Net profit of Geojit Financial Services declined 26.06% to Rs 16.54 crore in the quarter ended September 2026 as against Rs 22.37 crore during the previous quarter ended September 2025. Sales rose 2.56% to Rs 165.82 crore in the quarter ended September 2026 as against Rs 161.68 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	165.82	161.68	3
OPM %	18.30	19.07	-
PBDT	32.94	39.22	-16
PBT	20.62	30.31	-32
NP	16.54	22.37	-26

81,028.02 1,718.01 ( 2.17%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)